India Bets On Jan Aushadhi Kendras For HPV Vaccine To Prevent Cervical Cancer, Adds 116 New Drugs
Last Updated:
The list also includes medicines for heart diseases, diabetes, epilepsy, apart from various other types of cancers
The government's plan a roll out a nationwide HPV vaccination drive for girls to prevent cervical cancer remains stalled due to insufficient vaccine stock. To tide over the problem, the Narendra Modi government's flagship affordable generic drugs scheme, Jan Aushadhi, has now decided to include the HPV or Human Papillomavirus among 116 new medicines being added to its portfolio.
The final list of medicines, accessed by News18, lists the recombinant HPV quadrivalent vaccine, which is effective against diseases caused by HPV types 6, 11, 16, and 18. '…used for the prevention of HPV-associated cancers, such as cervical, vaginal, vulvar, and anal cancer", mentions the document in the category of usage of the drug. The vaccine is expected to be available at subsidised rates through Jan Aushadhi outlets. The objective of the planned offering is to offer timely access, even as the national rollout remains uncertain.
'While the meeting to discuss the status of the roll-out of the nationwide HPV vaccination campaign for girls (aged 9 to 14 years) is expected to take place during the last week of June, there is no update from the Serum Institute of India (SII) on the requested quantity of vaccine doses. Without them, we cannot decide timelines or go ahead," a senior government official told News18.
Meanwhile, the Union government is trying to expand access to HPV vaccines via Prime Minister Narendra Modi's flagship Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP).
'The scheme has just rolled out the tender for marketing the HPV vaccine as part of the initiative to add 116 more medicines to its existing bouquet of over 2,100 drugs and 315 surgical and medical devices," another senior government official said, adding that the price of the vaccine available at Jan Aushadhi retail outlets may not be steeply discounted.
However, it remains unclear how the tendering procedure will work as in India, only the Serum Institute of India is currently the licensed manufacturer of the HPV vaccine. For the private market in India, the HPV vaccine from SII — Cervavac — typically costs Rs 4,000 per dose.
Other Medicines on the List
The Jan Aushadhi scheme offers generic drugs priced at 50–90 per cent lower than their branded counterparts in the market. The new list of medicines will be available at 16,500 Jan Aushadhi Kendras across India by September.
'It takes three to six months to complete the procurement procedure and bring medicines onto the retail shelf. The list was finalised in March, and now the tendering process is underway," the second official said.
A significant portion of the medicines being added are for the treatment of heart disease and diabetes — two of India's most pressing health challenges. While India is often called the 'Diabetes Capital of the World,' with over 74 million adults affected, it also accounts for approximately 60 per cent of the world's heart disease burden.
The list also includes several cancer drugs, including Ibrutinib, used in the treatment of blood cancer and costing between Rs 7,000 and Rs 9,500, which severely hurts the pocket of middle and lower-income class patients and families. Also, the list includes Abiraterone Acetate, a drug used in the treatment of prostate cancer, blood cancer, Hodgkin's disease, and also prescribed in some cases of sickle cell anaemia. A bottle of 60 tablets of the drug costs around Rs 35,000. With inclusion under the scheme, the prices of these drugs—in their generic version—are expected to fall by at least 50 per cent.
Several other drugs for therapeutic categories such as the central nervous system, epilepsy and seizures, chronic obstructive pulmonary disease (COPD), anti-allergy and bone deficiencies are also part of the list.
In March, Union health minister JP Nadda said the scheme is helping over 10 lakh people access affordable medicines, leading to cumulative savings of Rs 30,000 crore. While the scheme has been helping those, who cannot afford branded medicines, if it manages to offer quality cancer drugs and the HPV vaccine at discounted prices, it could set a significant benchmark for public health affordability and access.
First Published:
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
4 hours ago
- News18
India Bets On Jan Aushadhi Kendras For HPV Vaccine To Prevent Cervical Cancer, Adds 116 New Drugs
Last Updated: The list also includes medicines for heart diseases, diabetes, epilepsy, apart from various other types of cancers The government's plan a roll out a nationwide HPV vaccination drive for girls to prevent cervical cancer remains stalled due to insufficient vaccine stock. To tide over the problem, the Narendra Modi government's flagship affordable generic drugs scheme, Jan Aushadhi, has now decided to include the HPV or Human Papillomavirus among 116 new medicines being added to its portfolio. The final list of medicines, accessed by News18, lists the recombinant HPV quadrivalent vaccine, which is effective against diseases caused by HPV types 6, 11, 16, and 18. '…used for the prevention of HPV-associated cancers, such as cervical, vaginal, vulvar, and anal cancer", mentions the document in the category of usage of the drug. The vaccine is expected to be available at subsidised rates through Jan Aushadhi outlets. The objective of the planned offering is to offer timely access, even as the national rollout remains uncertain. 'While the meeting to discuss the status of the roll-out of the nationwide HPV vaccination campaign for girls (aged 9 to 14 years) is expected to take place during the last week of June, there is no update from the Serum Institute of India (SII) on the requested quantity of vaccine doses. Without them, we cannot decide timelines or go ahead," a senior government official told News18. Meanwhile, the Union government is trying to expand access to HPV vaccines via Prime Minister Narendra Modi's flagship Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP). 'The scheme has just rolled out the tender for marketing the HPV vaccine as part of the initiative to add 116 more medicines to its existing bouquet of over 2,100 drugs and 315 surgical and medical devices," another senior government official said, adding that the price of the vaccine available at Jan Aushadhi retail outlets may not be steeply discounted. However, it remains unclear how the tendering procedure will work as in India, only the Serum Institute of India is currently the licensed manufacturer of the HPV vaccine. For the private market in India, the HPV vaccine from SII — Cervavac — typically costs Rs 4,000 per dose. Other Medicines on the List The Jan Aushadhi scheme offers generic drugs priced at 50–90 per cent lower than their branded counterparts in the market. The new list of medicines will be available at 16,500 Jan Aushadhi Kendras across India by September. 'It takes three to six months to complete the procurement procedure and bring medicines onto the retail shelf. The list was finalised in March, and now the tendering process is underway," the second official said. A significant portion of the medicines being added are for the treatment of heart disease and diabetes — two of India's most pressing health challenges. While India is often called the 'Diabetes Capital of the World,' with over 74 million adults affected, it also accounts for approximately 60 per cent of the world's heart disease burden. The list also includes several cancer drugs, including Ibrutinib, used in the treatment of blood cancer and costing between Rs 7,000 and Rs 9,500, which severely hurts the pocket of middle and lower-income class patients and families. Also, the list includes Abiraterone Acetate, a drug used in the treatment of prostate cancer, blood cancer, Hodgkin's disease, and also prescribed in some cases of sickle cell anaemia. A bottle of 60 tablets of the drug costs around Rs 35,000. With inclusion under the scheme, the prices of these drugs—in their generic version—are expected to fall by at least 50 per cent. Several other drugs for therapeutic categories such as the central nervous system, epilepsy and seizures, chronic obstructive pulmonary disease (COPD), anti-allergy and bone deficiencies are also part of the list. In March, Union health minister JP Nadda said the scheme is helping over 10 lakh people access affordable medicines, leading to cumulative savings of Rs 30,000 crore. While the scheme has been helping those, who cannot afford branded medicines, if it manages to offer quality cancer drugs and the HPV vaccine at discounted prices, it could set a significant benchmark for public health affordability and access. First Published:
Hans India
17 hours ago
- Hans India
Bihar: Gaya residents get eye treatment, free of cost under Ayushman Bharat Yojana
Lok Nayak Jaiprakash Eye Hospital, inaugurated five years ago in 2020, has become a landmark location in Bihar's Gaya, owing to its famed eye care centre catering to more than 10 lakh people, not just from the city but also adjoining towns including Nawada, Jehanabad, Aurangabad, and Nalanda. The hospital, situated at Kajha village of Wazirganj block of Gaya, is primarily an eye hospital, providing treatment for all types of eye diseases. The hospital has a modular Operation Theatre, two other OTs, 100 indoor patient beds and is equipped with a pathological lab, a spectacle and medicine shop, world-class diagnostic equipment, and a team of trained eye surgeons and paramedical staff. The hospital is again in the spotlight over providing free eye surgery to thousands of patients under the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB PM-JAY). About 40 per cent of the patients in the hospital are Ayushman cardholders and hence have access to medicines as well as surgeries free of cost under the yojana. Many Ayushman Bharat scheme beneficiaries shared their story with IANS and expressed gratitude to Prime Minister Narendra Modi for launching such a scheme. Balinder Singh of Bhedia village in Manpur block said: "I was treated under the Ayushman card. I got timely treatment, food and all facilities. If this card was not there, my treatment would not have been possible." 'In our family, my wife has this card. There is a younger boy, he will also get it made. I thank the central government for this scheme," he added. A woman named Malti Devi, who got her eyes treated at the hospital, said: "My card has been made. The eye operation has been done without any money spent. I want to thank the Modi government. With the help of the Central government, my eyes have been treated." She further stated: "This government is taking special care of the poor. Ayushman cards are being made in rural areas. This initiative is spreading awareness, also. People get to know from one person to another that eye treatment is being done in the hospital. This makes people aware, and they also get themselves treated. If this card had not been there, my eyes would not have been treated. This has been possible because of the Central government, and I want to thank PM Modi for this." Notably, the hospital provided eye care services to 26,240 OPD patients and performed cataract surgery on hundreds of patients through 637 rural eye camps last year. In view of its quality of services and social impact, it was also awarded a certificate of appreciation in 2022 and 2023.
Hans India
17 hours ago
- Hans India
Empowering women, empowering India: Nadda highlights transformative initiatives on 11 years of ‘Sashakt Nari'
Union Minister of Health and Family Welfare, J.P. Nadda, on Sunday emphasised the role of key government initiatives in transforming the lives of women across India, marking "11 years of Sashakt Nari" -- a sustained efforts toward women's empowerment under the leadership of Prime Minister Narendra Modi. "Initiatives such as the Nari Shakti Vandan Adhiniyam, PM Ujjwala Yojana, Drone Didi, the Swachh Bharat Abhiyan with its focus on toilet construction, Mahila Shakti Kendras, and Beti Bachao Beti Padhao have empowered our sisters and opened countless new opportunities," the Minister said in a post on social media platform X. He added that these schemes have placed women's aspirations at the heart of policymaking and governance. "Over the past 11 years, women have played an active role in every sector -- from healthcare and education to innovation and national defence," the Union Minister stated. "PM Modi's vision has ensured that women are not only included in the development journey but are leading it," he added. The Nari Shakti Vandan Adhiniyam, for instance, aims to increase women's participation in politics, while the Ujjwala Yojana has improved health and dignity for millions of rural women by providing clean cooking fuel. The innovative Drone Didi scheme is helping rural women learn drone operation for agricultural and logistical tasks, expanding both income and skill opportunities. Cleanliness and sanitation saw a significant boost through the Swachh Bharat Abhiyan, with an emphasis on toilet construction in homes and public spaces, bringing safety and dignity to women. Meanwhile, Mahila Shakti Kendras are offering support, training, and guidance to women at the grassroots, and Beti Bachao Beti Padhao continues to advocate for the rights and education of the girl child. As India celebrates #11YearsOfSashaktNari, Minister Nadda called on citizens to continue building a society where women feel secure, valued, and empowered to achieve their dreams.
